Studies have found that the expression of TRPC6 in prostate cancer cells is closely related to tumor stage and grade, suggesting that TRPC6 channels might be a novel anti-cancer drug target against prostate cancer (Yue et al., 2009). Here, TRPC6 is linked to prostate carcinoma.